Selected research
Market Structure
Global Engineered Bacterial Cell Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Engineered Bacterial Cell Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Engineered Bacterial Cell Protein include Calysta, Shougang Lanza Tech, Air Protein (Kiverdi), ICell Sustainable Nutrition, String Bio, Unibio, Arbiom, NovoNutrients and Superbrewed Food, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Engineered Bacterial Cell Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Engineered Bacterial Cell Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Engineered Bacterial Cell Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Engineered Bacterial Cell Protein market size, projected growth trends, production technologies, key applications, and end-use industries.
Engineered Bacterial Cell Protein Segment by Company
Calysta
Shougang Lanza Tech
Air Protein (Kiverdi)
ICell Sustainable Nutrition
String Bio
Unibio
Arbiom
NovoNutrients
Superbrewed Food
Solar Foods
Bond Pet Foods
Engineered Bacterial Cell Protein Segment by Type
Industrial Waste as Raw Material
Transform Engineering bacteria as Raw Material
Others
Engineered Bacterial Cell Protein Segment by Application
Food
Feed
Others
Engineered Bacterial Cell Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Engineered Bacterial Cell Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Engineered Bacterial Cell Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Engineered Bacterial Cell Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Engineered Bacterial Cell Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Engineered Bacterial Cell Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Engineered Bacterial Cell Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Engineered Bacterial Cell Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Industrial Waste as Raw Material
- Transform Engineering bacteria as Raw Material
- Others
Applications
- Food
- Feed
- Others
Companies covered
- Calysta
- Shougang Lanza Tech
- Air Protein (Kiverdi)
- ICell Sustainable Nutrition
- String Bio
- Unibio
- Arbiom
- NovoNutrients
- Superbrewed Food
- Solar Foods
- Bond Pet Foods
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Engineered Bacterial Cell Protein Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Engineered Bacterial Cell Protein Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Engineered Bacterial Cell Protein Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Engineered Bacterial Cell Protein Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Engineered Bacterial Cell Protein Market Dynamics
- 2.1 Engineered Bacterial Cell Protein Industry Trends
- 2.2 Engineered Bacterial Cell Protein Industry Drivers
- 2.3 Engineered Bacterial Cell Protein Industry Opportunities and Challenges
- 2.4 Engineered Bacterial Cell Protein Industry Restraints
3 Engineered Bacterial Cell Protein Market by Manufacturers
- 3.1 Global Engineered Bacterial Cell Protein Revenue by Manufacturers (2021-2026)
- 3.2 Global Engineered Bacterial Cell Protein Sales by Manufacturers (2021-2026)
- 3.3 Global Engineered Bacterial Cell Protein Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Engineered Bacterial Cell Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Engineered Bacterial Cell Protein Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Engineered Bacterial Cell Protein Manufacturers, Product Type & Application
- 3.7 Global Engineered Bacterial Cell Protein Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Engineered Bacterial Cell Protein Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Engineered Bacterial Cell Protein Players Market Share by Revenue in 2025
- 3.8.3 2025 Engineered Bacterial Cell Protein Tier 1, Tier 2, and Tier 3
4 Engineered Bacterial Cell Protein Market by Type
- 4.1 Engineered Bacterial Cell Protein Type Introduction
- 4.1.1 Industrial Waste as Raw Material
- 4.1.2 Transform Engineering bacteria as Raw Material
- 4.1.3 Others
- 4.2 Global Engineered Bacterial Cell Protein Sales by Type
- 4.2.1 Global Engineered Bacterial Cell Protein Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Engineered Bacterial Cell Protein Sales by Type (2021-2032)
- 4.2.3 Global Engineered Bacterial Cell Protein Sales Market Share by Type (2021-2032)
- 4.3 Global Engineered Bacterial Cell Protein Revenue by Type
- 4.3.1 Global Engineered Bacterial Cell Protein Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Engineered Bacterial Cell Protein Revenue by Type (2021-2032)
- 4.3.3 Global Engineered Bacterial Cell Protein Revenue Market Share by Type (2021-2032)
5 Engineered Bacterial Cell Protein Market by Application
- 5.1 Engineered Bacterial Cell Protein Application Introduction
- 5.1.1 Food
- 5.1.2 Feed
- 5.1.3 Others
- 5.2 Global Engineered Bacterial Cell Protein Sales by Application
- 5.2.1 Global Engineered Bacterial Cell Protein Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Engineered Bacterial Cell Protein Sales by Application (2021-2032)
- 5.2.3 Global Engineered Bacterial Cell Protein Sales Market Share by Application (2021-2032)
- 5.3 Global Engineered Bacterial Cell Protein Revenue by Application
- 5.3.1 Global Engineered Bacterial Cell Protein Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Engineered Bacterial Cell Protein Revenue by Application (2021-2032)
- 5.3.3 Global Engineered Bacterial Cell Protein Revenue Market Share by Application (2021-2032)
6 Global Engineered Bacterial Cell Protein Sales by Region
- 6.1 Global Engineered Bacterial Cell Protein Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Engineered Bacterial Cell Protein Sales by Region (2021-2032)
- 6.2.1 Global Engineered Bacterial Cell Protein Sales by Region (2021-2026)
- 6.2.2 Global Engineered Bacterial Cell Protein Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Engineered Bacterial Cell Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Engineered Bacterial Cell Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Engineered Bacterial Cell Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Engineered Bacterial Cell Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Engineered Bacterial Cell Protein Revenue by Region
- 7.1 Global Engineered Bacterial Cell Protein Revenue by Region
- 7.1.1 Global Engineered Bacterial Cell Protein Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Engineered Bacterial Cell Protein Revenue by Region (2021-2026)
- 7.1.3 Global Engineered Bacterial Cell Protein Revenue by Region (2027-2032)
- 7.1.4 Global Engineered Bacterial Cell Protein Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Engineered Bacterial Cell Protein Revenue (2021-2032)
- 7.2.2 North America Engineered Bacterial Cell Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Engineered Bacterial Cell Protein Revenue (2021-2032)
- 7.3.2 Europe Engineered Bacterial Cell Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Engineered Bacterial Cell Protein Revenue (2021-2032)
- 7.4.2 Asia-Pacific Engineered Bacterial Cell Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Engineered Bacterial Cell Protein Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Engineered Bacterial Cell Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Calysta
- 8.1.1 Calysta Company Information
- 8.1.2 Calysta Business Overview
- 8.1.3 Calysta Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Calysta Engineered Bacterial Cell Protein Product Portfolio
- 8.1.5 Calysta Recent Developments
- 8.2 Shougang Lanza Tech
- 8.2.1 Shougang Lanza Tech Company Information
- 8.2.2 Shougang Lanza Tech Business Overview
- 8.2.3 Shougang Lanza Tech Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shougang Lanza Tech Engineered Bacterial Cell Protein Product Portfolio
- 8.2.5 Shougang Lanza Tech Recent Developments
- 8.3 Air Protein (Kiverdi)
- 8.3.1 Air Protein (Kiverdi) Company Information
- 8.3.2 Air Protein (Kiverdi) Business Overview
- 8.3.3 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Product Portfolio
- 8.3.5 Air Protein (Kiverdi) Recent Developments
- 8.4 ICell Sustainable Nutrition
- 8.4.1 ICell Sustainable Nutrition Company Information
- 8.4.2 ICell Sustainable Nutrition Business Overview
- 8.4.3 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Product Portfolio
- 8.4.5 ICell Sustainable Nutrition Recent Developments
- 8.5 String Bio
- 8.5.1 String Bio Company Information
- 8.5.2 String Bio Business Overview
- 8.5.3 String Bio Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 String Bio Engineered Bacterial Cell Protein Product Portfolio
- 8.5.5 String Bio Recent Developments
- 8.6 Unibio
- 8.6.1 Unibio Company Information
- 8.6.2 Unibio Business Overview
- 8.6.3 Unibio Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Unibio Engineered Bacterial Cell Protein Product Portfolio
- 8.6.5 Unibio Recent Developments
- 8.7 Arbiom
- 8.7.1 Arbiom Company Information
- 8.7.2 Arbiom Business Overview
- 8.7.3 Arbiom Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Arbiom Engineered Bacterial Cell Protein Product Portfolio
- 8.7.5 Arbiom Recent Developments
- 8.8 NovoNutrients
- 8.8.1 NovoNutrients Company Information
- 8.8.2 NovoNutrients Business Overview
- 8.8.3 NovoNutrients Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 NovoNutrients Engineered Bacterial Cell Protein Product Portfolio
- 8.8.5 NovoNutrients Recent Developments
- 8.9 Superbrewed Food
- 8.9.1 Superbrewed Food Company Information
- 8.9.2 Superbrewed Food Business Overview
- 8.9.3 Superbrewed Food Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Superbrewed Food Engineered Bacterial Cell Protein Product Portfolio
- 8.9.5 Superbrewed Food Recent Developments
- 8.10 Solar Foods
- 8.10.1 Solar Foods Company Information
- 8.10.2 Solar Foods Business Overview
- 8.10.3 Solar Foods Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Solar Foods Engineered Bacterial Cell Protein Product Portfolio
- 8.10.5 Solar Foods Recent Developments
- 8.11 Bond Pet Foods
- 8.11.1 Bond Pet Foods Company Information
- 8.11.2 Bond Pet Foods Business Overview
- 8.11.3 Bond Pet Foods Engineered Bacterial Cell Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bond Pet Foods Engineered Bacterial Cell Protein Product Portfolio
- 8.11.5 Bond Pet Foods Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Engineered Bacterial Cell Protein Value Chain Analysis
- 9.1.1 Engineered Bacterial Cell Protein Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Engineered Bacterial Cell Protein Production Mode & Process
- 9.2 Engineered Bacterial Cell Protein Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Engineered Bacterial Cell Protein Distributors
- 9.2.3 Engineered Bacterial Cell Protein Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst